Independent fund research. Built on SEC filings.

How we research funds

ETF overlap

VHT vs VGHCX overlap: 55% of top holdings shared

Bottom line

How much do VHT and VGHCX overlap?

55% of their top holdings overlap by weight. 15 securities appear in both funds' top 25, making up 52.6% of VHT's assets and 47.0% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.

VHT holds far more positions (407 vs 97), so it is broader beyond the top names.

Updated Nov 22, 2026

Overlap at a glance

VHTVGHCX
Weight overlap (top 25)55%
Shared holdings15
Weight in shared holdings52.6%47.0%
Total positions40797
Expense ratio0.09%0.33%
Holdings as ofMay 31, 2026Jul 31, 2026

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Holdings VHT and VGHCX have in common

Holding% of VHT% of VGHCXOverlap
Eli Lilly & Co14.04%8.61%8.61%
Johnson & Johnson8.47%4.83%4.83%
AbbVie Inc6.09%2.30%2.30%
UnitedHealth Group Inc5.45%4.05%4.05%
Merck & Co Inc4.66%5.44%4.66%
Intuitive Surgical Inc2.38%2.52%2.38%
Danaher Corp1.84%2.18%1.84%
CVS Health Corp1.83%2.52%1.83%
Vertex Pharmaceuticals Inc1.80%2.36%1.80%
Elevance Health Inc1.35%1.83%1.35%
Boston Scientific Corp1.13%1.53%1.13%
Regeneron Pharmaceuticals Inc1.00%2.14%1.00%
HCA Healthcare Inc0.96%1.68%0.96%
Edwards Lifesciences Corp0.79%2.56%0.79%
Cencora Inc0.79%2.47%0.79%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Free weekly newsletter

The Fund Letter

Get fee cuts and hikes, fund closures and mergers, and one plain-English idea to make your portfolio cheaper — every week.

Free. Unsubscribe anytime. We never sell your email.

What each fund holds that the other doesn't

Top-25 holdings that appear in only one of the two funds' top 25.

Only in VHT

  1. Thermo Fisher Scientific Inc — 2.93%
  2. Amgen Inc — 2.87%
  3. Gilead Sciences Inc — 2.64%
  4. Pfizer Inc — 2.35%
  5. Abbott Laboratories — 2.35%
  6. Bristol-Myers Squibb Co — 1.84%
  7. Stryker Corp — 1.66%
  8. Medtronic PLC — 1.50%
  9. McKesson Corp — 1.45%
  10. Cigna Group/The — 1.17%

Only in VGHCX

  1. AstraZeneca PLC — 4.59%
  2. Gsk Plc — 3.00%
  3. Novartis AG — 1.91%
  4. Argenx SE — 1.68%
  5. Ucb Sa — 1.67%
  6. Agilent Technologies Inc — 1.49%
  7. Biogen Inc — 1.46%
  8. Galderma Group AG — 1.37%
  9. Roche Holding AG — 1.18%
  10. Dexcom Inc — 1.18%

Asset mix

Asset typeVHTVGHCX
Stocks99.8%97.6%
Repurchase agreements—2.2%
Cash & short-term funds0.2%0.1%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Country mix

CountryVHTVGHCX
US100.0%77.6%
GB—7.6%
JP—4.8%
CH—4.5%
BE—3.4%
DK—1.4%
HK—0.8%

Source: SEC Form N-PORT (periods May 31, 2026 / Jul 31, 2026)

Check another pair

FAQ

How much do VHT and VGHCX overlap?
About 55% by weight. 15 securities appear in both funds' top 25 holdings; they make up 52.6% of VHT's assets and 47.0% of VGHCX's. They share a meaningful core but differ in the rest of the portfolio.
What stocks do VHT and VGHCX have in common?
The largest shared holdings are Eli Lilly & Co, Johnson & Johnson, Merck & Co Inc, UnitedHealth Group Inc, Intuitive Surgical Inc.
Should I own both VHT and VGHCX?
They overlap in part. Owning both concentrates you in the shared names; check that the combined weight in those stocks is what you intend.
Which holds more stocks, VHT or VGHCX?
VHT is broader, with 407 positions versus 97 for VGHCX. Overlap here is measured on each fund's top 25 holdings, which carry most of the weight.

Overlap is computed from each fund's top 25 holdings in its latest SEC Form N-PORT filing, with weights normalized to the top 25; for each shared security we count the smaller of the two weights. Educational information, not investment advice.